Trial · NCT02426892
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Overall Response Rate (ORR) | ISA101 Vaccine and Nivolumab | Complete Response (CR) | 2 | Participants | |
| Number of Participants With Overall Response Rate (ORR) | ISA101 Vaccine and Nivolumab | Partial Response (PR) | 6 | Participants | |
| Median Progression Free Survival (PFS) | ISA101 Vaccine and Nivolumab | 2.66 | 95% Confidence Interval 2.5 to 9.44 | months | |
| Progression Free Survival (PFS) Rates at 2 and 3 Years | ISA101 Vaccine and Nivolumab | 2 Years | 12.5 | 95% Confidence Interval 4.3 to 36 | months |
| Progression Free Survival (PFS) Rates at 2 and 3 Years | ISA101 Vaccine and Nivolumab | 3 Years | 12.5 | 95% Confidence Interval 4.3 to 36 | months |
| Median Overall Survival | ISA101 Vaccine and Nivolumab | 15.3 | 95% Confidence Interval 10.6 to 27.2 | months | |
| Overall Survival (OS) Rates at 2 and 3 Years | ISA101 Vaccine and Nivolumab | 2 Years | 33 | 95% Confidence Interval 18.9 to 58.7 | months |
| Overall Survival (OS) Rates at 2 and 3 Years | ISA101 Vaccine and Nivolumab | 3 Years | 12.5 | 95% Confidence Interval 4.3 to 36 | months |
| Number of Participants With Adverse Events | ISA101 Vaccine and Nivolumab | Adverse Events | 23 | Participants | |
| Number of Participants With Adverse Events | ISA101 Vaccine and Nivolumab | Serious Adverse Events | 11 | Participants | |
| Number of Participants With Adverse Events | ISA101 Vaccine and Nivolumab | Death | 20 | Participants | |
| Number of Participants With Adverse Events | ISA101 Vaccine and Nivolumab | Laboratory Abnormalities | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02426892/results